The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...